![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
https://orcid.org/0000-0003-4441-4988
References
- Abalos E, Cuesta C, Grosso AL, Chou D, Say L. 2013. Global and regional estimates of preeclampsia and eclampsia: a systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology 170:1–7.
- [ACOG] ACOG Practice Bulletin No. 202. 2019. Gestational hypertension and preeclampsia. Obstetrics & Gynecology 133:e1–e25.
- Al-Rubaie ZTA, Askie LM, Hudson HM, Ray JG, Jenkins G, Lord SJ, et al. 2018. Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: an individual participant data meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 229:159–166.
- Chaemsaithong P, Pooh RK, Zheng M, Ma R, Chaiyasit N, Tokunaka M, et al. 2019. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. American Journal of Obstetrics and Gynecology 221:650.e1–650.e16.
- Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG, et al. 2014. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 160:695–703.
- Loussert L, Vidal F, Parant O, Hamdi SM, Vayssiere C, Guerby P, et al. 2020. Aspirin for prevention of preeclampsia and fetal growth restriction. Prenatal Diagnosis 40:519–527.
- Meher S, Duley L, Hunter K, Askie L. 2017. Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis. American Journal of Obstetrics and Gynecology 216:121–128.e2.
- [NICE] National Institute for Health and Care Excellence. 2010. Hypertension in pregnancy: diagnosis and management clinical guideline; [cited 2020 Feb 8]. Available from: https://www.nice.org.uk/guidance/cg107
- O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. 2016. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. American Journal of Obstetrics and Gynecology 214:103.e1–103.e12.
- O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, et al. 2017. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE Guidelines and ACOG Recommendations. Ultrasound in Obstetrics & Gynecology 49:756–760.
- Phumsiripaiboon P, Suksai M, Suntharasaj T, Geater A. 2020. Screening for pre-eclampsia: performance of National Institute for Health and Care Excellence guidelines versus American College of Obstetricians and Gynecologists Recommendations. Journal of Obstetrics and Gynaecology Research 46:2323–2331.
- Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. 2019. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. International Journal of Gynecology & Obstetrics 145:1–33.
- Rocha RS, Gurgel Alves JA, Bezerra Maia e Holanda Moura S, Araujo Júnior E, Martins WP, Vasconcelos CTM, et al. 2017. Comparison of three algorithms for prediction preeclampsia in the first trimester of pregnancy. Pregnancy Hypertension 10:113–117.
- Sandström A, Snowden JM, Höijer J, Bottai M, Wikström A-K. 2019. Clinical risk assessment in early pregnancy for preeclampsia in nulliparous women: a population based cohort study. PLoS One 14:e0225716.
- Sovio U, Smith G. 2019. Evaluation of a simple risk score to predict preterm pre-eclampsia using maternal characteristics: a prospective cohort study. BJOG 126:963–970.
- Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. 2015. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. American Journal of Obstetrics and Gynecology 213:62.e1–62.e10.
- Wright D, Tan MY, O’Gorman N, Poon LC, Syngelaki A, Wright A, et al. 2019. Predictive performance of the competing risk model in screening for preeclampsia. American Journal of Obstetrics and Gynecology 220:199.e1–199.e13.